Texture Analysis with 3.0-T MRI for Association of Response to Neoadjuvant Chemotherapy in Breast Cancer

医学 乳腺癌 接收机工作特性 随机森林 内科学 置信区间 新辅助治疗 磁共振成像 放射科 磁共振弥散成像 有效扩散系数 线性判别分析 核医学 癌症 人工智能 计算机科学
作者
Na Lae Eun,Daesung Kang,Eun Ju Son,Jeong Seon Park,Ji Hyun Youk,Jeong‐Ah Kim,Hye Mi Gweon
出处
期刊:Radiology [Radiological Society of North America]
卷期号:294 (1): 31-41 被引量:104
标识
DOI:10.1148/radiol.2019182718
摘要

Background Previous studies have suggested that texture analysis is a promising tool in the diagnosis, characterization, and assessment of treatment response in various cancer types. Therefore, application of texture analysis may be helpful for early prediction of pathologic response in breast cancer. Purpose To investigate whether texture analysis of features from MRI is associated with pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) in breast cancer. Materials and Methods This retrospective study included 136 women (mean age, 47.9 years; range, 31–70 years) who underwent NAC and subsequent surgery for breast cancer between January 2012 and August 2017. Patients were monitored with 3.0-T MRI before (pretreatment) and after (midtreatment) three or four cycles of NAC. Texture analysis was performed at pre- and midtreatment T2-weighted MRI, contrast material–enhanced T1-weighted MRI, diffusion-weighted MRI, and apparent diffusion coefficient (ADC) mapping by using commercial software. A random forest method was applied to build a predictive model for classifying those with pCR with use of texture parameters. Diagnostic performance for predicting pCR was assessed and compared with that of six other machine learning classifiers (adaptive boosting, decision tree, k-nearest neighbor, linear support vector machine, naive Bayes, and linear discriminant analysis) by using the Wald test and DeLong method. Results Forty of the 136 patients (29%) achieved pCR after NAC. In the prediction of pCR, the random forest classifier showed the lowest diagnostic performance with pretreatment ADC (area under the receiver operating characteristic curve [AUC], 0.53; 95% confidence interval: 0.44, 0.61) and the highest diagnostic performance with midtreatment contrast-enhanced T1-weighted MRI (AUC, 0.82; 95% confidence interval: 0.74, 0.88) among pre- and midtreatment T2-weighted MRI, contrast-enhanced T1-weighted MRI, diffusion-weighted MRI, and ADC mapping. Conclusion Texture parameters using a random forest method of contrast-enhanced T1-weighted MRI at midtreatment of neoadjuvant chemotherapy were valuable and associated with pathologic complete response in breast cancer. © RSNA, 2019 Online supplemental material is available for this article.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
高挑的鑫磊关注了科研通微信公众号
1秒前
AA18236931952发布了新的文献求助10
3秒前
3秒前
3秒前
4秒前
柴桑青木完成签到,获得积分0
5秒前
7秒前
卷毛维安完成签到,获得积分10
7秒前
闫辰龙发布了新的文献求助10
8秒前
小林发布了新的文献求助10
9秒前
英俊的铭应助AA18236931952采纳,获得10
9秒前
李华完成签到,获得积分10
10秒前
10秒前
10秒前
nathaliess完成签到,获得积分10
11秒前
11秒前
慕青应助稳重雁易采纳,获得30
11秒前
13秒前
jason完成签到,获得积分10
13秒前
NaNA完成签到,获得积分10
14秒前
啦啦啦完成签到,获得积分10
14秒前
14秒前
王志新完成签到,获得积分10
15秒前
无辜的笑蓝完成签到,获得积分10
15秒前
15秒前
Sicily发布了新的文献求助10
16秒前
林夏完成签到,获得积分10
16秒前
Imcarie完成签到 ,获得积分10
18秒前
肆_完成签到 ,获得积分10
18秒前
无极微光应助缓慢咖啡采纳,获得20
18秒前
18秒前
量子星尘发布了新的文献求助10
19秒前
赫连烙发布了新的文献求助10
19秒前
19秒前
20秒前
20秒前
ququ完成签到,获得积分20
21秒前
隐形曼青应助狄百招采纳,获得10
23秒前
23秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
List of 1,091 Public Pension Profiles by Region 1581
以液相層析串聯質譜法分析糖漿產品中活性雙羰基化合物 / 吳瑋元[撰] = Analysis of reactive dicarbonyl species in syrup products by LC-MS/MS / Wei-Yuan Wu 1000
Current Trends in Drug Discovery, Development and Delivery (CTD4-2022) 800
Biology of the Reptilia. Volume 21. Morphology I. The Skull and Appendicular Locomotor Apparatus of Lepidosauria 600
The Scope of Slavic Aspect 600
Foregrounding Marking Shift in Sundanese Written Narrative Segments 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5537074
求助须知:如何正确求助?哪些是违规求助? 4624638
关于积分的说明 14592736
捐赠科研通 4565155
什么是DOI,文献DOI怎么找? 2502201
邀请新用户注册赠送积分活动 1480908
关于科研通互助平台的介绍 1452098